AGM/EGM8 Sept 2026, 08:41 pm
Orchid Pharma Files FY26 Annual Report, Announces AGM
AI Summary
Orchid Pharma Ltd has filed its Annual Report for the Financial Year 2025-26, which includes the Notice for its 33rd Annual General Meeting (AGM). The AGM is scheduled for September 29, 2026, at 12:00 PM IST, to be conducted via Video Conferencing/Other Audio Visual Means. The report details the company's financial highlights, statutory reports, and financial statements, including standalone and consolidated figures. It also contains a 'Safe Harbour' statement regarding forward-looking statements and discusses the amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited. The Annual Report and AGM notice are available on the company's website.
Key Highlights
- FY26 Annual Report filed, including AGM notice.
- AGM scheduled for September 29, 2026, via VC/OAVM.
- Report covers financial highlights and statements.
- Details amalgamation with Dhanuka Laboratories.
- Forward-looking statements included with risk disclosures.
Price Impact
More from ORCHPHARMA